Vistim Labs Information

Vistim Labs is a neurodiagnostic software helping clinicians treat dementia patients. Our mission is to accelerate diagnosis by improving clinical decision making ability with our proprietary artificial intelligence platform, so patients receive timely proper diagnosis. We are valued for our ability to estimate multiple dementia endpoints in a single test. Endpoints like: cognitive performance, amyloid & tau accumulation, and neurodegeneration. We are the first tool used in the dementia diagnostic pathway and are unique in our ability to provide these endpoints in a way that is non-invasive, FDA compliant, and fully reimbursed. Our technology is built on fundamental biomarkers of cognitive decline, which we've expanded to estimate other endpoints; however, these biomarkers demonstrate additional utility in predicting symptomatic onset of disease and for measuring efficacy of treatment for emerging interventions. In this way, patients can receive the most effective treatments that are optimized to them and their outcomes, for maximum patient satisfaction. We are an early stage biotechnology startup that uses artificial intelligence and machine learning with EEG. If you'd like to get in touch, please reach out to our CEO, James Hamet.